← Back to Discover
SUPERSTRING CAPITAL MANAGEMENT LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $158,379,902
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- COGENT BIOSCIENCES INC · COM · 19240Q201 · shares: $13,285,091
- AXSOME THERAPEUTICS INC. · COM · 05464T104 · shares: $13,197,019
- GENMAB A/S · SPONSORED ADS · 372303206 · shares: $11,828,582
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $10,700,963
- TREVI THERAPEUTICS INC · COM · 89532M101 · shares: $9,776,778
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $9,561,206
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares: $8,856,785
- VIR BIOTECHNOLOGY INC · COM · 92764N102 · shares: $8,699,050
- IMMUNOVANT INC · COM · 45258J102 · shares: $8,028,419
- UROGEN PHARMA LTD · COM · M96088105 · shares: $7,040,318
Reported holdings
32 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 343,284 shares | $13,285,091 |
| AXSOME THERAPEUTICS INC. | COM | 05464T104 | — | 53,916 shares | $13,197,019 |
| GENMAB A/S | SPONSORED ADS | 372303206 | — | 430,600 shares | $11,828,582 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 287,583 shares | $10,700,963 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 524,224 shares | $9,776,778 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 51,053 shares | $9,561,206 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 188,282 shares | $8,856,785 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 853,685 shares | $8,699,050 |
| IMMUNOVANT INC | COM | 45258J102 | — | 208,368 shares | $8,028,419 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 191,313 shares | $7,040,318 |
| CLIMB BIO INC | COM | 28658R106 | — | 521,082 shares | $6,794,909 |
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | — | 552,501 shares | $6,353,762 |
| SAVARA INC | COM | 805111101 | — | 977,460 shares | $6,021,154 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 125,432 shares | $4,495,483 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 406,077 shares | $4,397,814 |
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | — | 7,172 shares | $3,886,005 |
| VAXCYTE INC | COM | 92243G108 | — | 66,793 shares | $3,882,677 |
| BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | — | 12,273 shares | $3,497,437 |
| CABALETTA BIO INC | COM | 12674W109 | — | 1,278,652 shares | $3,478,020 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 155,813 shares | $2,960,447 |
| SIONNA THERAPEUTICS INC | COM | 829401108 | — | 63,156 shares | $2,778,232 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 30,456 shares | $2,138,011 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 257,675 shares | $1,363,101 |
| CYBIN INC | COM NEW | 23256X407 | — | 204,424 shares | $1,351,243 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 18,867 shares | $1,206,545 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 25,623 shares | $906,798 |
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260839 | — | 63,648 shares | $812,148 |
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | — | 121,457 shares | $463,966 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 14,175 shares | $354,375 |
| BOUNDLESS BIO INC | COM | 10170A100 | — | 55,356 shares | $138,390 |
| BIOMEA FUSION INC | COM | 09077A106 | — | 250,000 shares | $85,306 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 61,269 shares | $39,868 |